STERIS (STE) to Release Earnings on Thursday

STERIS (NYSE:STE - Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect STERIS to post earnings of $2.33 per share and revenue of $1.38 billion for the quarter. STERIS has set its FY25 guidance at $9.05-$9.25 EPS and its FY 2025 guidance at 9.050-9.250 EPS.Persons that wish to listen to the company's earnings conference call can do so using this link.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, topping analysts' consensus estimates of $2.12 by $0.02. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the company posted $2.03 earnings per share. The firm's quarterly revenue was up 7.3% on a year-over-year basis. On average, analysts expect STERIS to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

STERIS Trading Up 1.4 %

STERIS stock traded up $3.01 during trading hours on Thursday, reaching $223.29. 114,727 shares of the company's stock traded hands, compared to its average volume of 434,035. STERIS has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The firm's 50 day moving average is $211.90 and its 200-day moving average is $224.77. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.55 and a current ratio of 2.41. The firm has a market capitalization of $22.04 billion, a price-to-earnings ratio of 50.97 and a beta of 0.84.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a dividend of $0.57 per share. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. STERIS's dividend payout ratio (DPR) is presently 52.05%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on STE shares. StockNews.com downgraded shares of STERIS from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, October 29th. JMP Securities restated a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research report on Monday, November 18th. Piper Sandler upgraded STERIS from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $230.00 to $260.00 in a report on Thursday, October 24th. Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research report on Friday, November 8th. Finally, Stephens reiterated an "overweight" rating and issued a $260.00 price objective on shares of STERIS in a research report on Thursday, November 7th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $262.50.

Insiders Place Their Bets

In other news, SVP Cary L. Majors sold 1,682 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total transaction of $365,532.24. Following the transaction, the senior vice president now owns 11,372 shares in the company, valued at approximately $2,471,363.04. This trade represents a 12.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.14% of the company's stock.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.